176 related articles for article (PubMed ID: 21813491)
21. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
22. Duration of risperidone treatment for BPSD.
Snowdon J; Brodaty H; Ames D; Day S
Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
[No Abstract] [Full Text] [Related]
23. Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.
Weintraub D; Katz IR
Psychiatr Clin North Am; 2005 Dec; 28(4):941-83, ix-x. PubMed ID: 16325736
[No Abstract] [Full Text] [Related]
24. Current attitudes regarding treatment of agitation and psychosis in dementia.
Serby MJ; Roane DM; Lantz MS; Cohen AJ; Turok A; Perlis TE
Am J Geriatr Psychiatry; 2009 Feb; 17(2):174. PubMed ID: 19155750
[No Abstract] [Full Text] [Related]
25. Psychosis, agitation, and antipsychotic treatment in dementia.
Devanand DP
Am J Psychiatry; 2013 Sep; 170(9):957-60. PubMed ID: 24030608
[No Abstract] [Full Text] [Related]
26. Atypical antipsychotics, elderly patients, and mortality risk.
Citrome L
South Med J; 2007 Oct; 100(10):964-5. PubMed ID: 17943033
[No Abstract] [Full Text] [Related]
27. To treat or not to treat? Managing acute symptoms in an elderly patient with Alzheimer's disease.
Deegan R; Bailey KP
J Psychosoc Nurs Ment Health Serv; 2001 Oct; 39(10):12-5. PubMed ID: 11697070
[No Abstract] [Full Text] [Related]
28. Risks and benefits of antipsychotic drugs in elderly patients with dementia.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2008 Nov; 46(11):19-23. PubMed ID: 19051574
[TBL] [Abstract][Full Text] [Related]
29. Beneficial effects of perospirone on aggressive behavior associated with dementia.
Sato S; Mizukami K; Moro K; Tanaka Y; Asada T
Psychiatry Clin Neurosci; 2006 Feb; 60(1):106-9. PubMed ID: 16472367
[TBL] [Abstract][Full Text] [Related]
30. [Cerebral infarct and atypical antipsychotic agents].
Lacomblez L
Psychol Neuropsychiatr Vieil; 2004 Dec; 2(4):299. PubMed ID: 15706675
[No Abstract] [Full Text] [Related]
31. Psychotic symptoms, aggression and restlessness in dementia.
Ballard C; Gray A; Ayre G
Rev Neurol (Paris); 1999; 155 Suppl 4():S44-52. PubMed ID: 10637938
[TBL] [Abstract][Full Text] [Related]
32. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes.
Mueller C; John C; Perera G; Aarsland D; Ballard C; Stewart R
Eur J Epidemiol; 2021 Jan; 36(1):89-101. PubMed ID: 32415541
[TBL] [Abstract][Full Text] [Related]
33. Significance of findings in aripiprazole for treatment of psychoses in Alzheimer dementia.
Tsai AC
Am J Geriatr Psychiatry; 2008 Jul; 16(7):613; author reply 614. PubMed ID: 18591582
[No Abstract] [Full Text] [Related]
34. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial.
Mowla A; Pani A
J Clin Psychopharmacol; 2010 Feb; 30(1):40-3. PubMed ID: 20075646
[TBL] [Abstract][Full Text] [Related]
35. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S
Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475
[No Abstract] [Full Text] [Related]
36. Confusion, agitation and rigidity: early signs of NMS?
Velamoor VR; Swamy GN; Parmar RS
Can J Psychiatry; 1992 May; 37(4):280. PubMed ID: 1351791
[No Abstract] [Full Text] [Related]
37. Neuroleptic treatment of agitation and psychosis in dementia.
Devanand DP; Levy SR
J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S18-27. PubMed ID: 8561840
[TBL] [Abstract][Full Text] [Related]
38. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study.
De Deyn PP; Eriksson H; Svensson H;
Int J Geriatr Psychiatry; 2012 Mar; 27(3):296-304. PubMed ID: 21538537
[TBL] [Abstract][Full Text] [Related]
39. Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.
Devanand DP; Pelton GH; D'Antonio K; Strickler JG; Kreisl WC; Noble J; Marder K; Skomorowsky A; Huey ED
Alzheimer Dis Assoc Disord; 2017; 31(1):73-75. PubMed ID: 27819842
[No Abstract] [Full Text] [Related]
40. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimer's Disease (CATIE-AD): baseline characteristics.
Ismail MS; Dagerman K; Tariot PN; Abbott S; Kavanagh S; Schneider LS
Curr Alzheimer Res; 2007 Jul; 4(3):325-35. PubMed ID: 17627490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
